Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Quarterly results
CC transcript
Asset disposition
Inv. presentation
HARVARD BIOSCIENCE INC (HBIO) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/08/2023 8-K Quarterly results
Docs: "Q2 Revenues of $28.8 million"
03/09/2023 8-K Quarterly results
Docs: "Harvard Bioscience Announces Fourth Quarter 2022 Financial Results HOLLISTON, Mass., March 9, 2023"
11/08/2022 8-K Quarterly results
Docs: "Harvard Bioscience Announces Third Quarter 2022 Financial Results"
08/04/2022 8-K Quarterly results
Docs: "Harvard Bioscience Announces Second Quarter 2022 Financial Results HOLLISTON, Mass., August 3, 2022"
05/04/2022 8-K Quarterly results
03/08/2022 8-K Quarterly results
11/03/2021 8-K Quarterly results
Docs: "Harvard Bioscience Announces Third Quarter 2021 Financial Results"
08/05/2021 8-K Quarterly results
05/06/2021 8-K Quarterly results
03/10/2021 8-K Quarterly results
11/05/2020 8-K Quarterly results
Docs: "Harvard Bioscience Announces Third Quarter 2020 Financial Results"
08/05/2020 8-K Quarterly results
05/05/2020 8-K Quarterly results
02/26/2020 8-K/A Quarterly results
02/26/2020 8-K Quarterly results
11/05/2019 8-K Quarterly results
Docs: "SECOND AMENDMENT TO FINANCING AGREEMENT",
"Harvard Bioscience Announces Third Quarter Financial Results"
05/02/2019 8-K Quarterly results
Docs: "Harvard Bioscience Reports First Quarter 2019 Financial Results Reports both GAAP and adjusted non-GAAP revenue of $28.2 million, an increase of 5% and 2%, respectively"
03/18/2019 8-K/A Quarterly results
Docs: "Harvard Bioscience Reports Strong Fourth Quarter and Year-End 2018 Results, and Issues 2019 Financial Guidance -Reports record Fourth Quarter GAAP and adjusted non-GAAP revenue of $33.9 million, a year-over-year increase of 56% and 24%, respectively- HOLLISTON, MA – February 28, 2019 -- Harvard Bioscience, Inc. , a global developer, manufacturer and marketer of a broad range of solutions to advance life science, reported its financial results for the fourth quarter and full year ended December 31, 2018. “I am extremely proud of our team’ s fourth quarter execution. In addition to strong growth in adjusted gross profit, adjusted operating income, and adjusted earnings per share, we also reported record quarterly revenue of $33.9 million”, said Jeffrey Duchemin, President and CEO of Harvard ..."
02/28/2019 8-K Quarterly results
10/25/2018 8-K Quarterly results
Docs: "Harvard Bioscience Reports Third Quarter 2018 Financial Results"
07/26/2018 8-K Quarterly results
Docs: "Harvard Bioscience Reports Second Quarter 2018 Financial Results"
05/02/2018 8-K Quarterly results
Docs: "Harvard Bioscience Reports First Quarter 2018 Financial Results"
03/01/2018 8-K Quarterly results
Docs: "Harvard Bioscience Reports Fourth Quarter and Year-End 2017 Results"
10/26/2017 8-K Quarterly results
Docs: "Harvard Bioscience Reports Third Quarter 2017 Financial Results"
07/27/2017 8-K Quarterly results
Docs: "Harvard Bioscience Reports Second Quarter 2017 Financial Results"
04/27/2017 8-K Form 8-K - Current report
03/09/2017 8-K Form 8-K - Current report
10/27/2016 8-K Form 8-K - Current report
07/28/2016 8-K Form 8-K - Current report
05/12/2016 8-K Form 8-K - Current report
04/29/2016 8-K Form 8-K - Current report
10/29/2015 8-K Quarterly results
04/30/2015 8-K Quarterly results, Resignation/termination of a director
Docs: "Harvard Bioscience Reports First Quarter 2015 Financial Results Conference Call to be Held at 11:00 AM ET Today",
"Harvard Bioscience Appoints James Green to the Board of Directors and Announces Retirement of Robert Dishman From the Board"
02/26/2015 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy